Skip to main content
. Author manuscript; available in PMC: 2020 Sep 4.
Published in final edited form as: Exp Hematol. 2019 Jun 29;75:64–73.e4. doi: 10.1016/j.exphem.2019.06.474

Figure 4.

Figure 4.

Survival analysis of AML patients with respect to CD97 expression after stratification based on patient transplant status. (A) Overall survival of AML patients with CD97 high (Z score ≥1) versus CD97 low (Z score <1) in patients who did not receive a transplant. (B) Overall survival of AML patients with CD97 high (Z score ≥1) versus CD97 low (Z score <1) in patients who received a transplant. (C) Disease-free survival of AML patients with CD97 high (Z score ≥1) versus CD97 low (Z score <1) in patients who did not receive a transplant. (D) Disease-free survival of AML patients with CD97 high (Z score ≥1) versus CD97 low (Z score <1) in patients who received a transplant.